Loading...
NPI 1174729016 · Little Rock, AR · Retina Specialist (Ophthalmology) Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Paul Hruby is a retina specialist (ophthalmology) physician provider located in Little Rock, Arkansas. This profile covers 16 Medicare and 3 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Paul Hruby |
| Address | 9800 Baptist Health Dr Ste 200 |
| City | Little Rock |
| State | AR |
| ZIP | 72205 |
| Taxonomy | Retina Specialist (Ophthalmology) Physician |
| NPI Enumerated | June 26, 2007 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $3.1M |
| Medicaid | $20.8K |
PAUL HRUBY is a retina specialist (Ophthalmology) physician based in LITTLE ROCK, AR with an NPI enumerated (registered) 2007-06-26 (~19 years ago). The specialty taxonomy and tenure are consistent with a long-standing retinal practice focused on medical and diagnostic management of posterior segment disease.
This provider’s payer mix is heavily Medicare-dominated: total Medicare revenue is $3.1M versus total Medicaid revenue of $20.8K, indicating Medicare drives the economics of the practice and Medicaid activity is effectively minimal. The scale difference suggests the practice should be considered effectively single-payer in revenue impact.
Medicare revenue is highly concentrated in intravitreal biologic and injection services: J0178 accounts for 51.6% of the provider’s Medicare revenue, J2777 accounts for 32.4%, and 67028 accounts for 5.2% — the precomputed top-3 share is 89.2% of Medicare revenue. This mix points to a service-line built around serial intravitreal injections (anti-VEGF and related agents) as the primary revenue generator.
Claims-level detail reinforces an injection-centric practice: on Medicare the provider billed 2.3K claims for J0178 with $692 avg paid/claim, and 34.4K claims for J2777 with $29 avg paid/claim, while 67028 shows 2K claims with $82 avg paid/claim. These volumes and per-claim payments indicate reliance on frequent biologic administration alongside procedure-level intravitreal injection coding.
Clinical follow-up and diagnostic imaging are also substantial on Medicare: 92134 appears with 3K claims and $26 avg paid/claim and 92012 appears with 1.6K claims and $58 avg paid/claim. Both 92012 (rank #145 of 17177, 99th percentile) and 92134 (rank #409 of 26868, 98th percentile) are labeled as "extreme outlier" volumes nationally, signaling far-above-typical use of intermediate exams and retinal imaging consistent with intensive monitoring of retinal disease.
Competitive standing for the top injection codes is higher-than-average volume but characterized in the dataset as typical for the modality: J0178 ranks #399 of 3204 providers nationally (88th percentile; typical, unremarkable volume), J2777 ranks #231 of 2039 (89th percentile; typical, unremarkable volume), and 67028 ranks #431 of 4255 (90th percentile; typical, unremarkable volume). In plain terms, the provider is a relatively high-volume injector nationally but not identified as an outlier for intravitreal injection codes.
Medicaid billing is small and fully concentrated in three codes (precomputed top-3 share 100.0%): 92134 (43.3% of Medicaid revenue; 687 claims; $13 avg paid/claim), 67028 (37.8%; 100 claims; $78 avg paid/claim), and 92012 (18.9%; 300 claims; $13 avg paid/claim). In-state ranks are modest: 92134 is #13 of 43 (71st percentile) while 67028 is #13 of 17 (25th percentile), which together suggest limited Medicaid penetration for injection services and a greater Medicaid role in diagnostic imaging.
From an operational and reimbursement perspective, the practice’s revenue is highly sensitive to utilization and reimbursement patterns for J0178 and J2777 (which together drive the majority of Medicare revenue) and to the heavy imaging/exam workflow signaled by extreme outlier status for 92012 and 92134. Given total Medicare revenue of $3.1M and total Medicaid revenue of $20.8K, payers and analysts should focus on biologic/injection utilization trends and imaging/exam frequency when assessing network value or negotiating arrangements.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
16 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 2,300 | $690 | $1.6M |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 34,440 | $30 | $998.8K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 1,950 | $80 | $160.2K |
| 92012 | For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any… | 1,600 | $60 | $92.9K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 2,990 | $30 | $77.7K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 540 | $80 | $42.4K |
| J2778 | Injection, ranibizumab, 0.1 mg | 220 | $180 | $39.6K |
| J9035 | Injection, bevacizumab, 10 mg | 460 | $60 | $25.9K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 190 | $110 | $21.9K |
| 67108 | The provider repairs a detached retina using heat produced by a laser beam or by freezing the tissues. He may attach a scleral buckle to simplify the passage of fluid through and behind the retina or… | 10 | $850 | $9.3K |
Showing 1–10 of 16
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 16 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
3 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 690 | $10 | $8.9K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 100 | $80 | $7.8K |
| 92012 | For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any… | 300 | $10 | $3.9K |
How this provider's Medicaid billing volume and revenue compare to other Arkansas providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Arkansas median
3 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 13 | 20 | 260 | $110 | $91.6K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 13 | 40 | 260 | $20 | $26.2K |
| 92012 | For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any… | 27 | 100 | 120 | $30 | $14.3K |
Other providers in the same ZIP code as Paul Hruby, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.